These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27399074)

  • 1. Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report.
    Kim SI; Jin YJ; Cho SG; Shin WY; Kim JM; Lee JW
    Medicine (Baltimore); 2016 Jul; 95(27):e3987. PubMed ID: 27399074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric and duodenal ischaemia after transarterial chemoembolisation for hepatocellular carcinoma: an unexpected but significant complication.
    Chintalapati SP; Patel A; Conjeevaram H
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29467124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma].
    Son MY; Han BH; Lee SU; Yun BC; Seo KI; Huh JD
    Korean J Gastroenterol; 2020 Jun; 75(6):351-355. PubMed ID: 32581207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of acute ischemic duodenal ulcer associated with superior mesenteric artery dissection after transarterial chemoembolization for hepatocellular carcinoma.
    Jang ES; Jeong SH; Kim JW; Lee SH; Yoon CJ; Kang SG
    Cardiovasc Intervent Radiol; 2009 Mar; 32(2):367-70. PubMed ID: 18931873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Unusual Complication of Transarterial Chemoembolization of Hepatocellular Carcinoma; Pseudoaneurysm: A Case Report.
    Atay M; Ozdemir H
    Curr Med Imaging; 2022; 18(11):1244-1247. PubMed ID: 35339188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma].
    Park YH; Kang SH; Kim SU; Kim DY; Park JY; Ahn SH; Han KH; Chon CY
    Korean J Gastroenterol; 2011 Sep; 58(3):149-52. PubMed ID: 21960103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.
    Zen C; Zen Y; Mitry RR; Corbeil D; Karbanová J; O'Grady J; Karani J; Kane P; Heaton N; Portmann BC; Quaglia A
    Liver Transpl; 2011 Aug; 17(8):943-54. PubMed ID: 21491582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary complications of arterial chemoembolization of hepatocellular carcinoma.
    Dhamija E; Paul SB; Gamanagatti SR; Acharya SK
    Diagn Interv Imaging; 2015 Nov; 96(11):1169-75. PubMed ID: 26292615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma.
    Wan X; Zhai X; Yan Z; Yang P; Li J; Wu D; Wang K; Xia Y; Shen F
    Oncotarget; 2016 Dec; 7(50):83806-83816. PubMed ID: 27566566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
    Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
    Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ischemic cholecystitis after transarterial chemoembolization of hepatocellular carcinoma: incidence and clinical outcome.
    Wagnetz U; Jaskolka J; Yang P; Jhaveri KS
    J Comput Assist Tomogr; 2010; 34(3):348-53. PubMed ID: 20498534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications after TACE in HCC - complications after transarterial chemoembolization (TACE) in hepatocellular carcinoma].
    Schneeweiß S; Horger M; Ketelsen D; Ioanoviciu SD
    Rofo; 2015 Feb; 187(2):79-82. PubMed ID: 25629286
    [No Abstract]   [Full Text] [Related]  

  • 17. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.
    Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic gastroduodenal ulcer as a complication of hepatic hepatocarcinoma transarterial chemoembolization].
    de Zárraga Mata C; Thomás Salom G; Maura Oliver ÁL
    Rev Gastroenterol Peru; 2019; 39(4):367-369. PubMed ID: 32097399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a safety index of transarterial chemoembolization for hepatocellular carcinoma to prevent acute liver damage.
    Hwang JI; Chow WK; Hung SW; Li TC; Cheng YP; Ho YJ; Lin CC
    Anticancer Res; 2005; 25(3c):2551-4. PubMed ID: 16080491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.